The Quantellect read.As of Nov 19, 2026, 8 active firms cover STAAR Surgical Company: 4 rate it Buy or better, 3 sit at Neutral, and 1 rate it Sell or worse, a neutral consensus. Targets span $19.00 to $37.00, a moderate spread. The average target of $28.38 sits 12% above the current $25.36. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 3 to 4 over recent months. On the fundamentals, the Street sees revenue growth near 29% this year and 8% next, consensus EPS building from about $0.35 next quarter toward $1.13 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS8 active firms
Neutral
Strong Buy00%
Buy450%
Neutral338%
Sell113%
Strong Sell00%
Based on 8 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$28.38
+11.9% upside
Average target across 8 active firms as of Nov 19, 2026 vs $25.36 current
Highest Target$37.00
Average Target$28.38
Lowest Target$19.00
Detailed analyst forecasts for STAA
Showing 1–8 of 8 named analysts shown · 8 active firms in the rating projection
As of Nov 19, 2026, 4 of 8 active firms rate STAA a Buy (3 Neutral, 1 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
STAA EPS & revenue forecast
EPS · NEXT QUARTER
$0.35
Range $0.29 – $0.41 · 3 analysts · +18% YoY
Next period, 3 analysts expect STAAR Surgical Company to earn $0.35 a share (range $0.29 – $0.41), versus $0.29 a year earlier. Full-year consensus is $0.93, growing to $1.13 the year after.
REVENUE · NEXT QUARTER
$101.6M
Range $94.2M – $105.1M · 3 analysts · +88% YoY
Revenue is expected to reach $101.6M (range $94.2M – $105.1M), +88.0% year-over-year. Full-year consensus is $338.9M, rising to $366.6M next year.
Top analysts covering STAAR Surgical Company
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on STAA.
#1
Anthony Petrone
Mizuho · Rank #121
Neutral
$27.00+6.5% to target
Overall win rate
45%
+ Follow
#2
MC
Mason Carrico
Stephens & Co. · Rank #178
Neutral
$17.00-33.0% to target
Overall win rate
40%
+ Follow
#3
Ryan Zimmerman
BTIG · Rank #212
Neutral
No targeton STAA
Overall win rate
37%
+ Follow
#4
David Saxon
Needham · Rank #426
Neutral
No targeton STAA
Overall win rate
32%
+ Follow
#5
Matt O'Brien
Piper Sandler · Rank #561
Neutral
$16.00-36.9% to target
Overall win rate
25%
+ Follow
STAA stock forecast FAQ
What is STAA's average 12-month price target?+
The 8 active firms with a live target average $28.38 for STAAR Surgical Company over the next 12 months, ranging from a $37.00 high to a $19.00 low, as of Nov 19, 2026.
Is STAA stock a Buy, Sell or Neutral right now?+
The current consensus is Neutral. Of the 8 active firms as of Nov 19, 2026, 4 rate it Buy or Strong Buy, 3 rate it Neutral, and 1 rate it Sell or Strong Sell.
What are the highest and lowest price targets for STAA?+
The Street-high target is $37.00 (Wedbush), and the Street-low is $19.00 (UBS). The average of all 8 active-firm targets is $28.38.
How many active Wall Street firms cover STAA?+
8 active firms have a recognized rating on STAAR Surgical Company as of Nov 19, 2026, and 8 active firms carry a live 12-month price target.
Who is the most accurate analyst covering STAA?+
Among analysts who currently cover STAA, Anthony Petrone of Mizuho has the strongest overall Quantellect track record (Rank #121). Their current call is Neutral with a $27.00 target.
What is STAAR Surgical Company's projected EPS for next quarter?+
The consensus estimate is $0.35 per share (range $0.29 – $0.41) across 3 analysts. Full-year EPS is projected at $0.93, rising to $1.13 the following year.
How much revenue is STAAR Surgical Company expected to report next quarter?+
Consensus revenue is $101.6M (range $94.2M – $105.1M). Full-year revenue is projected at $338.9M, growing to $366.6M next year.
Have analysts been upgrading or downgrading STAA lately?+
As of Nov 19, 2026, 4 of 8 active firms rate STAA a Buy (3 Neutral, 1 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their STAA calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.